We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
XEOMIN (Merz Australia Pty Ltd)
Product name
XEOMIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
180 working days (255)
Active ingredients
incobotulinum toxin A
Registration type
EOI
Indication
XEOMIN is now also indicated for the treatment of:
- Spasticity of upper limb
- Upper facial lines
- Lateral periorbital lines (crow's feet)
- Horizontal forehead lines